Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
Bethesda, Maryland, United States In 2008 was created MidCap Financial, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Bethesda.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the MidCap Financial, startups are often financed by New Leaf Venture Partners, Wellington Partners, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Silicon Valley Bank, Oxford Finance LLC, WuXi NextCODE. In the next rounds fund is usually obtained by Foresite Capital, CRG L.P., WuXi NextCODE.
The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Intarcia Therapeutics, Spectranetics, DNAnexus
The fund is generally included in 2-6 deals every year. Comparing to the other companies, this MidCap Financial performs on 30 percentage points more the average number of lead investments. Speaking about the real fund results, this Corporate Investor is 21 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2014. Deals in the range of 50 - 100 millions dollars are the general things for fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Beijing Wanxiang Shiba Media Investment Management | Beijing, Beijing, China |
| BuiltUp Ventures | Israel, Tel Aviv, Tel Aviv |
| Graph Ventures | California, Palo Alto, United States |
| Gravity Payments | Seattle, United States, Washington |
| Hyperplane Venture Capital | Boston, Massachusetts, United States |
| Lough Shore Investments | Belfast, Northern Ireland, United Kingdom |
| Nirvana Digital Investment Holding Co Ltd | - |
| Roadzen | New York, New York, United States |
| Sangam Ventures | Chattarpur, Delhi, India |
| The Still River Fund | Boston, Massachusetts, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Marco | $200M | 27 Feb 2023 | Miami, Florida, United States | ||
Bovie Medical | $10M | 21 Feb 2023 | Clearwater, Florida, United States | ||
ViewRay | $125M | 14 Nov 2022 | Cleveland, Ohio, United States | ||
SurModics | $125M | 17 Oct 2022 | Birmingham, Alabama, United States | ||
Carbon6 Technologies | $66M | 04 Oct 2022 | Washington, Pennsylvania, United States | ||
TELA Bio | $50M | 31 May 2022 | Pennsylvania, United States | ||
Forge Biologics | $80M | 10 Jan 2022 | Ohio, United States | ||
Aterian | $50M | 27 Dec 2021 | New York, New York, United States | ||
UPSTACK | $100M | 02 Nov 2021 | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
